United Therapeutics | UTHR - Sales Revenues

United Therapeutics reported $516M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Sales Change
Amarin AMRN:US USD 89.88M 4.56M
Baxter International BAX:US USD 3.89B 114M
Biogen BIIB:US USD 2.54B 35.5M
Esperion Therapeutics ESPR:US USD 18.82M 162K
Gilead Sciences GILD:US USD 7.39B 347M
GlaxoSmithKline GSK:LN GBP 7.38B 453M
Johnson & Johnson JNJ:US USD 23.71B 85M
Pfizer PFE:US USD 24.29B 1.65B
Regeneron Pharmaceuticals REGN:US USD 3.41B 478.2M
Sangamo Biosciences SGMO:US USD 27.23M 770K
Seattle Genetics SGEN:US USD 528.15M 17.85M
Teva Pharmaceutical TEVA:IT USD 3.88B 289M
Vertex Pharmaceuticals VRTX:US USD 2.3B 31.6M